NasdaqGM - Delayed Quote • USD
Vaxxinity, Inc. (VAXX)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 7:45 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -0.1 | -0.1 | -0.46 | -0.38 |
| Low Estimate | -0.1 | -0.1 | -0.46 | -0.38 |
| High Estimate | -0.1 | -0.1 | -0.46 | -0.38 |
| Year Ago EPS | -0.16 | -0.15 | -0.6 | -0.46 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| CURRENCY IN USD | 12/31/2022 | 3/31/2023 | 6/30/2023 | 9/30/2023 |
|---|---|---|---|---|
| EPS Est. | -0.16 | -0.16 | -0.15 | -0.12 |
| EPS Actual | -0.16 | -0.15 | -0.11 | -0.1 |
| Difference | 0 | 0.01 | 0.04 | 0.02 |
| Surprise % | 0.00% | 6.30% | 26.70% | 16.70% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| Current Estimate | -0.1 | -0.1 | -0.46 | -0.38 |
| 7 Days Ago | -0.1 | -0.1 | -0.46 | -0.38 |
| 30 Days Ago | -0.1 | -0.1 | -0.46 | -0.38 |
| 60 Days Ago | -0.1 | -0.1 | -0.46 | -0.38 |
| 90 Days Ago | -0.1 | -0.1 | -0.46 | -0.38 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | VAXX | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 37.50% | -- | -- | 6.50% |
| Next Qtr. | 33.30% | -- | -- | 12.00% |
| Current Year | 23.30% | -- | -- | 5.30% |
| Next Year | 17.40% | -- | -- | 13.10% |
| Next 5 Years (per annum) | -51.60% | -- | -- | 11.09% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Initiated | Baird: Outperform | 9/8/2023 |
| Initiated | Evercore ISI Group: In-Line | 4/27/2022 |
| Initiated | Jefferies: Buy | 12/7/2021 |
| Initiated | B of A Securities: Buy | 12/6/2021 |
Related Tickers
PHIO Phio Pharmaceuticals Corp.
0.6820
+1.34%
FNCH Finch Therapeutics Group, Inc.
2.3200
+3.11%
ASLN ASLAN Pharmaceuticals Limited
0.4153
-7.30%
HEPA Hepion Pharmaceuticals, Inc.
1.3700
+6.20%
KTRA Kintara Therapeutics, Inc.
0.1488
-5.82%
TOVX Theriva Biologics, Inc.
0.4195
+2.33%
NKGN NKGen Biotech, Inc.
1.6100
-18.69%
TVGN Tevogen Bio Holdings Inc.
1.0000
+17.65%
AZTR Azitra, Inc.
0.2185
-0.73%
ABEO Abeona Therapeutics Inc.
3.2600
+2.19%